T. Rowe Price Associates’s Herbalife HLF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.65M | Buy |
111,804
+15,034
| +16% | +$246K | ﹤0.01% | 1919 |
|
|
2025
Q4 | $1.25M | Sell |
96,770
-9,950
| -9% | -$105K | ﹤0.01% | 1983 |
|
|
2025
Q3 | $901K | Buy |
106,720
+5,203
| +5% | +$49.1K | ﹤0.01% | 2117 |
|
|
2025
Q2 | $876K | Buy |
101,517
+4,605
| +5% | +$34.2K | ﹤0.01% | 2044 |
|
|
2025
Q1 | $837K | Buy |
96,912
+10,629
| +12% | +$75.6K | ﹤0.01% | 2047 |
|
|
2024
Q4 | $578K | Sell |
86,283
-8,072
| -9% | -$60K | ﹤0.01% | 2228 |
|
|
2024
Q3 | $679K | Buy |
94,355
+5,584
| +6% | +$51.4K | ﹤0.01% | 2125 |
|
|
2024
Q2 | $923K | Buy |
88,771
+6,484
| +8% | +$64.8K | ﹤0.01% | 1927 |
|
|
2024
Q1 | $827K | Buy |
82,287
+3,647
| +5% | +$39.2K | ﹤0.01% | 1994 |
|
|
2023
Q4 | $1.2M | Buy |
78,640
+2,550
| +3% | +$35.2K | ﹤0.01% | 1768 |
|
|
2023
Q3 | $1.06M | Buy |
76,090
+4,367
| +6% | +$66K | ﹤0.01% | 1766 |
|
|
2023
Q2 | $950K | Buy |
71,723
+791
| +1% | +$10.8K | ﹤0.01% | 1840 |
|
|
2023
Q1 | $1.14M | Buy |
70,932
+1,770
| +3% | +$31.3K | ﹤0.01% | 1721 |
|
|
2022
Q4 | $1.03M | Buy |
69,162
+1,425
| +2% | +$24.8K | ﹤0.01% | 1756 |
|
|
2022
Q3 | $1.35M | Buy |
67,737
+705
| +1% | +$17.5K | ﹤0.01% | 1609 |
|
|
2022
Q2 | $1.37M | Buy |
67,032
+14,514
| +28% | +$359K | ﹤0.01% | 1746 |
|
|
2022
Q1 | $1.59M | Buy |
52,518
+4,760
| +10% | +$186K | ﹤0.01% | 1789 |
|
|
2021
Q4 | $1.96M | Buy |
47,758
+1,551
| +3% | +$64.5K | ﹤0.01% | 1719 |
|
|
2021
Q3 | $1.96M | Buy |
46,207
+386
| +0.8% | +$19.1K | ﹤0.01% | 1734 |
|
|
2021
Q2 | $2.42M | Sell |
45,821
-955
| -2% | -$47.5K | ﹤0.01% | 1674 |
|
|
2021
Q1 | $2.08M | Buy |
46,776
+1,127
| +2% | +$55.6K | ﹤0.01% | 1699 |
|
|
2020
Q4 | $2.19M | Sell |
45,649
-12
| -0% | -$579 | ﹤0.01% | 1606 |
|
|
2020
Q3 | $2.13M | Sell |
45,661
-2,887
| -6% | -$142K | ﹤0.01% | 1541 |
|
|
2020
Q2 | $2.18M | Sell |
48,548
-12,070
| -20% | -$469K | ﹤0.01% | 1517 |
|
|
2020
Q1 | $1.77M | Sell |
60,618
-4,767
| -7% | -$177K | ﹤0.01% | 1534 |
|
|
2019
Q4 | $3.12M | Buy |
65,385
+2,965
| +5% | +$128K | ﹤0.01% | 1487 |
|
|
2019
Q3 | $2.36M | Buy |
62,420
+336
| +0.5% | +$13.1K | ﹤0.01% | 1535 |
|
|
2019
Q2 | $2.65M | Sell |
62,084
-905
| -1% | -$42.9K | ﹤0.01% | 1509 |
|
|
2019
Q1 | $3.34M | Sell |
62,989
-105
| -0.2% | -$6.03K | ﹤0.01% | 1461 |
|
|
2018
Q4 | $3.72M | Buy |
63,094
+154
| +0.2% | +$8.5K | ﹤0.01% | 1437 |
|
|
2018
Q3 | $3.43M | Sell |
62,940
-2,680
| -4% | -$148K | ﹤0.01% | 1503 |
|
|
2018
Q2 | $3.52M | Buy |
65,620
+2,514
| +4% | +$132K | ﹤0.01% | 1483 |
|
|
2018
Q1 | $3.08M | Buy |
63,106
+5,784
| +10% | +$246K | ﹤0.01% | 1490 |
|
|
2017
Q4 | $1.94M | Buy |
57,322
+182
| +0.3% | +$6.38K | ﹤0.01% | 1595 |
|
|
2017
Q3 | $1.94M | Sell |
57,140
-3,980
| -7% | -$136K | ﹤0.01% | 1585 |
|
|
2017
Q2 | $2.18M | Sell |
61,120
-22,640
| -27% | -$763K | ﹤0.01% | 1538 |
|
|
2017
Q1 | $2.44M | Buy |
83,760
+24,212
| +41% | +$674K | ﹤0.01% | 1528 |
|
|
2016
Q4 | $1.43M | Buy |
59,548
+3,814
| +7% | +$104K | ﹤0.01% | 1650 |
|
|
2016
Q3 | $1.73M | Sell |
55,734
-4,000
| -7% | -$126K | ﹤0.01% | 1573 |
|
|
2016
Q2 | $1.75M | Sell |
59,734
-978
| -2% | -$29.3K | ﹤0.01% | 1554 |
|
|
2016
Q1 | $1.87M | Buy |
60,712
+4,820
| +9% | +$124K | ﹤0.01% | 1538 |
|
|
2015
Q4 | $1.5M | Sell |
55,892
-908
| -2% | -$25.2K | ﹤0.01% | 1590 |
|
|
2015
Q3 | $1.55M | Sell |
56,800
-8,000
| -12% | -$219K | ﹤0.01% | 1590 |
|
|
2015
Q2 | $1.78M | Hold |
64,800
| – | – | ﹤0.01% | 1615 |
|
|
2015
Q1 | $1.39M | Buy |
64,800
+7,200
| +13% | +$123K | ﹤0.01% | 1654 |
|
|
2014
Q4 | $1.09M | Hold |
57,600
| – | – | ﹤0.01% | 1700 |
|
|
2014
Q3 | $1.26M | Sell |
57,600
-7,662
| -12% | -$205K | ﹤0.01% | 1675 |
|
|
2014
Q2 | $2.11M | Buy |
65,262
+200
| +0.3% | +$6.13K | ﹤0.01% | 1566 |
|
|
2014
Q1 | $1.86M | Sell |
65,062
-213,938
| -77% | -$7.07M | ﹤0.01% | 1562 |
|
|
2013
Q4 | $11M | Sell |
279,000
-12,200
| -4% | -$423K | ﹤0.01% | 1260 |
|
|
2013
Q3 | $10.2M | Sell |
291,200
-21,200
| -7% | -$656K | ﹤0.01% | 1272 |
|
|
2013
Q2 | $7.05M | Buy |
+312,400
| New | +$6.65M | ﹤0.01% | 1328 |
|
Other funds holding HLF
BG
ROIC
VPM
VCM
T. Rowe Price Associates's HLF Position: Q1 2026 in Review
T. Rowe Price Associates increased its Herbalife (HLF) stake by 16% in Q1 2026, buying an estimated $246K and bringing the position to 111,804 shares worth $1.65M. The position accounts for ﹤0.01% of the portfolio, ranked #1919.
T. Rowe Price Associates first reported a position in HLF in Q2 2013 and has held it in 52 quarters since. The position peaked at $11M in Q4 2013. 252 funds tracked by Wall St. Rank hold HLF as of Q1 2026.
- T. Rowe Price Associates held 111,804 shares of Herbalife worth $1.65M as of Q1 2026.
- T. Rowe Price Associates bought 15,034 Herbalife shares in Q1 2026, an estimated $246K.
- Herbalife made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #1919 holding.
- T. Rowe Price Associates first reported a position in Herbalife in Q2 2013 and has held it in 52 quarters since.
- T. Rowe Price Associates's Herbalife position peaked at $11M in Q4 2013.
- 252 funds tracked by Wall St. Rank held Herbalife as of Q1 2026.
Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.